Method of producing isoprenoid compounds in yeast
Yeast strains capable of increased prenyl phosphate production are provided, enabling increased terpenoid molecule production. Heterologous yeast strains with high prenyl phosphate availability are prepared using one or both of two different strategies for increasing the availability of prenyl phosphates for terpenoid production. First, by co-expressing multiple mevalonate pathway gene analogs, a novel heterologous combination of genes results, some of which increases the inherent availability of prenyl phosphates in yeast. Second, by expressing the non-endogenous enzyme ATP citrate lysase (ACL), a buildup of high cytosolic concentration of acetyl-CoA is produced in the cytosol of S. cerevisiae.
1. A method of producing an isoprenoid compound in a yeast cell, comprising cultivating the yeast cell in a suitable medium, wherein the yeast cell comprises:
a) one or more heterologous nucleic acids encoding MEV-1 of SEQ ID. NO: 36, MEV-6 of SEQ ID. NO: 41, MEV-15 of SEQ ID. NO: 50, MEV-18 of SEQ ID. NO: 53, MEV-21 of SEQ ID. NO: 56, or MEV-23 of SEQ ID. NO: 58;
b) a heterologous promoter substituted for the endogenous promoter of the cellular aconitase (ACO1) gene; and
c) a heterologous nucleotide sequence encoding an ATP-citrate lyase enzyme;
wherein the yeast cell has reduced inherent aconitase (ACO1) expression relative to an unaltered yeast cell.
2. The method of claim 1 , wherein the yeast cell further comprises one or more heterologous nucleotide sequences encoding a product set forth in MEV-6 of SEQ ID. NO: 41, MEV-15 of SEQ ID. NO: 50, MEV-18 of SEQ ID. NO: 53, MEV-21 of SEQ ID. NO: 56, or MEV-23 of SEQ ID. NO: 58.
3. The method of claim 1 , wherein the yeast cell further comprises one or more heterologous nucleotide sequences encoding a product involved in the biosynthesis pathway leading to an isoprenoid compound of one or more MEVs set forth in SEQ ID NOS: 36 to 70.
4. The method of claim 1 , wherein the yeast cell further comprises one or more nucleic acids of SEQ ID NOS: 1-35.
5. The method of claim 1 , wherein the heterologous promoter substituted for the endogenous promoter of the cellular aconitase (ACO1) gene is a CUP1 gene promoter.
6. The method of claim 1 , further comprising recovering the isoprenoid compound.
7. The method of 1 , wherein the isoprenoid compound is β-carotene, antheraxanthin, adonirubin, adonixanthin, astaxanthin, canthaxanthin, capsorubrin, β-cryptoxanthin, α-carotene, β,ψ-carotene, Δ-carotene, ε-carotene, echinenone, 3-hydroxyechinenone, 3′-hydroxyechinenone, γ-carotene, ψ-carotene, 4-keto-γ-carotene, ζ-carotene, α-cryptoxanthin, deoxyflexixanthin, diatoxanthin, 7,8-didehydroastaxanthin, didehydrolycopene, fucoxanthin, fucoxanthinol, isorenieratene, β-isorenieratene, lactucaxanthin, lutein, lycopene, myxobactone, neoxanthin, neurosporene, hydroxyneurosporene, peridinin, phytoene, rhodopin, rhodopin glucoside, 4-keto-rubixanthin, siphonaxanthin, spheroidene, spheroidenone, spirilloxanthin, torulene, 4-keto-torulene, 3-hydroxy-4-keto-torulene, uriolide, uriolide acetate, violaxanthin, zeaxanthin-β-diglucoside, zeaxanthin, or C30 carotenoids.
8. The method of claim 1 , wherein each heterologous nucleic acid comprises one or more of MEV-1 of SEQ ID. NO: 1, MEV-6 of SEQ ID. NO: 6, MEV-15 of SEQ ID. NO: 15, MEV-18 of SEQ ID. NO: 18, MEV-21 of SEQ ID. NO: 21, or MEV-23 of SEQ ID. NO: 23.
9. The method of claim 1 , wherein the yeast cell further comprises reduced inherent ERG9 expression relative to an unaltered yeast cell.
10. The method of claim 1 , wherein the yeast host cell produces at least about 25 fold more isoprenoid compound relative to an unaltered yeast cell.
11. The method of claim 1 , wherein the isoprenoid compound is produced in a recoverable amount of at least 150 mg/g dry weight (DW).
12. The method of claim 1 , wherein the ATP-citrate lyase enzyme is a Chlamydomonas rheinhardtii or Yarrowia lipolytica ATP-citrate lyase enzyme.
13. A method for making a yeast host cell with increased synthesis of isoprenoid compounds relative to an unaltered yeast cell, the method comprising
a) introducing one or more heterologous nucleotide sequences encoding MEV-1 of SEQ ID. NO: 36, MEV-6 of SEQ ID. NO: 41, MEV-15 of SEQ ID. NO: 50, MEV-18 of SEQ ID. NO: 53, MEV-21 of SEQ ID. NO: 56, or MEV-23 of SEQ ID. NO: 58;
b) a heterologous promoter substituted for the endogenous promoter of the cellular aconitase (ACO1) gene; and
c) a heterologous nucleotide sequence encoding an ATP-citrate lyase enzyme;
wherein the yeast host cell has reduced inherent aconitase (ACO1) expression relative to an unaltered yeast cell.
14. A yeast host cell comprising
a) one or more heterologous nucleotide sequences encoding MEV-1 of SEQ ID. NO: 36, MEV-6 of SEQ ID. NO: 41, MEV-15 of SEQ ID. NO: 50, MEV-18 of SEQ ID. NO: 53, MEV-21 of SEQ ID. NO: 56, or MEV-23 of SEQ ID. NO: 58;
b) a heterologous promoter substituted for the endogenous promoter of the cellular aconitase (ACO1) gene; and
c) a heterologous nucleotide sequence encoding an ATP-citrate lyase enzyme;
wherein the yeast host cell has reduced inherent aconitase (ACO1) expression relative to an unaltered yeast cell.
15. The yeast host cell of claim 14 , wherein the nucleotide sequence comprises one or more of MEV-1 of, MEV-6 of SEQ ID. NO: 6, MEV-15 of SEQ ID. NO: 15, MEV-18 of SEQ ID. NO: 18, MEV-21 of SEQ ID. NO: 21, or MEV-23 of SEQ ID. NO: 23.
16. The yeast cell of claim 14 , wherein the yeast cell further comprises one or more heterologous nucleotide sequences encoding a product set forth in MEV-6 of SEQ ID. NO: 41, MEV-15 of SEQ ID. NO: 50, MEV-18 of SEQ ID. NO: 53, MEV-21 of SEQ ID. NO: 56, or MEV-23 of SEQ ID. NO: 58.